MBX Biosciences seeks up to $482.5 million valuation in US IPO
(Reuters) - MBX Biosciences, which is developing peptide therapies for treating endocrine…
(Reuters) - MBX Biosciences, which is developing peptide therapies for treating endocrine…
(Reuters) - Wall Street's top regulator on Monday gave the nod to new accounting…
By Hannah Lang(Reuters) - Losses from cryptocurrency-related frauds and scams increased…
(Reuters) -Social media platform X was back up on Saturday after it suffered an outage…
(Reuters) - Elon Musk's AI startup xAI has discussed a deal that would give it some…
WASHINGTON (Reuters) - Former U.S. President George W. Bush, a Republican, does not plan…
BEIJING (Reuters) - China is "dissatisfied" with the Dutch goverment's…
(Reuters) - The S&P Dow Jones Indices said on Friday server maker Dell Technologies,…
By Trevor Hunnicutt and Michelle NicholsWASHINGTON (Reuters) - Any Iranian transfer of…
(Reuters) -Apple’s latest iPhone with its A18 chip, which is set to be unveiled at an…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.